KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Work In Process (2016 - 2017)

Amgen (AMGN) has 5 years of Work In Process data on record, last reported at $1.6 billion in Q2 2017.

  • For Q2 2017, Work In Process changed N/A year-over-year to $1.6 billion; the TTM value through Jun 2017 reached $1.6 billion, changed N/A, while the annual FY2016 figure was $1.6 billion, 5.17% up from the prior year.
  • Work In Process reached $1.6 billion in Q2 2017 per AMGN's latest filing, up from $1.5 billion in the prior quarter.
  • Across five years, Work In Process topped out at $2.1 billion in Q4 2013 and bottomed at $1.3 billion in Q2 2015.
  • Average Work In Process over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2014.
  • Peak YoY movement for Work In Process: dropped 28.1% in 2015, then grew 5.17% in 2016.
  • A 5-year view of Work In Process shows it stood at $2.1 billion in 2013, then dropped by 24.85% to $1.6 billion in 2014, then decreased by 1.42% to $1.5 billion in 2015, then increased by 5.17% to $1.6 billion in 2016, then grew by 0.62% to $1.6 billion in 2017.
  • Per Business Quant database, its latest 3 readings for Work In Process were $1.6 billion in Q2 2017, $1.5 billion in Q1 2017, and $1.6 billion in Q4 2016.